NIH starts trial of Pear, Chess apps for opioid use disorder

Patient recruitment has begun in a National Institutes of Health (NIH) trial of two digital therapeutics (DTx) for people with opioid use disorder (OUD), developed by Pear Therapeutics and

Orexo eyes real-world testing of its modia opioid use disord...

Orexo will start a new study of its modia app – used to treat people with opioid use disorder – to test how it performs in real-world settings.

Digital therapies for opioid use disorder need more data, sa...

There isn’t enough evidence to suggest that digital therapies for people with opioid use disorder (OUD) can improve on standard interventions, according to the Institute for Clinical and Ec

Orexo eyes opioid use disorder app launch before year-end

Sweden’s Orexo says its opioid use disorder (OUD) digital therapeutic – now christened Modia – is on course for a launch before the end of the year in the US.

Orexo partners with Lyfebulb to study addiction during pande...

With drinking and drug use said to be spiking during the pandemic, Orexo has teamed up with US organisation Lyfebulb to research how the crisis is affecting people with addicti

Orexo partners with Gaia on digital opioid abuse therapeutic